Immune Cell-Based Therapies for COVID-19
Immune Cell-based Therapies for COVID-19: Current Clinical Trial Landscape Data One element of COVID-19 is a hyper-response of the patient’s immune system, which in turn leads to lung injury and acute respiratory distress syndrome.1 At the same time, appropriate immune response is decreased due to immune evasion by the virus. 1,2 Treatment with immune cell-based adoptive therapies is […]